Christopher Wilcox, Ph.D., R&D Director, Pharma, Nutrition and Functional Ingredients at Kerry. Chris is a speaker in the "Biopharmaceutical Raw Materials" track at the 2013 event.

Jennifer Garner, Senior Engineer, Vaccine Technology Integration, Raw Materials, Merck. Jennifer is a speaker in the "Biopharmaceutical Raw Materials" track at the 2013 event.

Key Elements of Process Design: Risk Assessments, Design Space and Control Strategy
Amit Banerjee, Ph.D., Research Fellow, Global Biologics, Pfizer, Inc.

Challenges and Strategies for Establishing a Vendor Network for Antibody Drug Conjugates
Vincent Turula, Ph.D., Director, Biotherapeutics & Vaccines Outsourcing, Pfizer, Inc.

Viral Risk Mitigation Strategy: In-Process Monitoring of Rodent Parvovirus in CHO Manufacturing Process Using Real-Time PCR
Serge Monpoeho, Ph.D., Senior Manager, QC Virology & Mycoplasma,

Enhancing Viral Spikes for Nanofiltration Studies with Different Viral Purification Techniques and QC Characterization Including DLS - Particle Analysis
Joseph Hughes, Ph.D., Chief Scientist of Virology and VP of Service Development, Wuxi Apptec

Microbial Detection Array for Product Safety and Public Health
Crystal Jaing, Ph.D., Group Leader, Applied Genomics, Lawrence Livermore National Laboratory

Electrospray Differential Mobility Analysis (ES-DMA): An Emerging Technology for Viral Identification, Characterization and Clearance
Leonard Pease, Ph.D., Professor, Departments of Chemical Engineering, Pharmaceutics & Pharmaceutical Chemistry and Internal Medicine, University of Utah

Risk Assessment and Management for Adventitious Agents in Raw Materials Used in the Biopharmaceutical Industry
Barbara J. Potts, Ph.D., Senior Consultant, Potts and Nelson Consulting, LLC

Applying a Risk-based Product Protection Strategy to a New Mammalian Cell Culture Bioprocessing Facility
Marie Murphy, Ph.D., Microbiologist, Biotechnology Operations, Eli Lilly, Ireland

Overview of Regulations, Strategies and Methods Used to Minimize the Risk of Virus Contamination of Biopharmaceutical Processes and Products through Raw Materials
Horst Ruppach, Ph.D., Global Manager of Viral Clearance and Global Coordinator Virology, Charles River Biopharmaceutical Services, Germany Mitigating Risk of Raw Material Contamination by Adventitious Agents

Risk-Based Measures for Adventitious Agents in Developing Viral Vaccines
Roya Ravanbakhsh, Director, Quality Assurance, PaxVax, Inc.

Strategies to Reduce Production Disturbances and Performance Variability Introduced by Raw Materials used in Product Manufacturing Operations
Victor J. Melendez Colon, Ph.D., Principal Scientist, Process Development, Amgen Manufacturing, Limited, Puerto Rico

End-to-End Raw Materials Management in Vaccine Manufacturing Processes
Humberto Vega Mercado, Ph.D., Technology Product Lead - Hep A Vaccine, Technology Operations, Merck & Co.